Literature DB >> 19427604

Management of prosthetic heart valve obstruction: fibrinolysis versus surgery. Early results and long-term follow-up in a single-centre study of 263 cases.

Raymond Roudaut1, Stephane Lafitte, Marie-Françoise Roudaut, Patricia Reant, Xavier Pillois, Catherine Durrieu-Jaïs, Pierre Coste, Claude Deville, Xavier Roques.   

Abstract

Optimal management of prosthetic heart valve obstruction (PHVO) remains controversial even though surgery is usually recommended. To better define the efficacy and safety of fibrinolysis versus surgery in the pre- and post-transoesophageal echocardiography (TEE) eras. We analysed initial results and follow-up data from a large, retrospective, single-centre series, comparing fibrinolysis and surgery in patients with PHVO treated over 20 years. Two hundred and sixty-three consecutive episodes of PHVO in 210 patients, mainly left sided, were managed in our institution by either fibrinolysis (n=127) or surgery (n=136). Early clinical evolution was assessed in terms of haemodynamic success and complications. Concerning early results, there were no significant differences between the two groups in terms of mortality (10%). However, haemodynamic success was significantly more frequent in the surgical group (89% versus 70.9% p<0.001), embolic episodes were significantly more frequent in the fibrinolysis group (15% versus 0.7%, p<0.001), as were total complications (25.2% versus 11.1%, p=0.005). Long-term follow-up, with a mean duration of 6 years (range: 0-20), was obtained and showed significantly better results in the surgical group in terms of recurrence (p=0.021) and mortality (p=0.002). In univariate and multivariable analyses, NYHA functional class at presentation was a strong predictor of late death (p<0.01). Management of patients during the pre- and post-TEE eras was significantly different, since introduction of TEE surgery has become the preferred therapeutic strategy. Results of this extensive single-centre experience indicate that since the introduction of TEE, surgery is more frequently performed than fibrinolysis due to the improvement of thromboembolic risk assessment. Furthermore, prompt surgical treatment is associated with a better early success rate and a significantly lower incidence of complications than fibrinolysis in left-sided PHVO. However, fibrinolysis may be justified in selected cases. Long-term follow-up showed significantly better results in the surgical group in terms of recurrence and mortality.

Entities:  

Mesh:

Year:  2009        PMID: 19427604     DOI: 10.1016/j.acvd.2009.01.007

Source DB:  PubMed          Journal:  Arch Cardiovasc Dis        ISSN: 1875-2128            Impact factor:   2.340


  17 in total

1.  Dysfunction of mechanical heart valve prosthesis: experience with surgical management in 48 patients.

Authors:  Wei-Guo Ma; Bin Hou; Adiljan Abdurusul; Ding-Xu Gong; Yue Tang; Qian Chang; Jian-Ping Xu; Han-Song Sun
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

2.  Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Richard P Whitlock; Jack C Sun; Stephen E Fremes; Fraser D Rubens; Kevin H Teoh
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Successful treatment of aortic prosthetic valve thrombosis with bolus dose Tenecteplase.

Authors:  Pramod Kumar Kuchulakanti; Sateesh Chirde; Raghvender Akkala
Journal:  Indian Heart J       Date:  2014-03-04

4.  Effect of a combined anti-thrombotic therapy of thrombosis on prosthetic heart valves.

Authors:  Wei Wei; Taiming Dong; Zhichao Zheng; Shuping Huang
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

5.  Timing of adverse events during fibrinolytic therapy with streptokinase for left-sided prosthetic valve thrombosis.

Authors:  Ganesan Karthikeyan; Navin Mathew; Ravi S Math; Niveditha Devasenapathy; Shyam S Kothari; Vinay K Bahl
Journal:  J Thromb Thrombolysis       Date:  2011-08       Impact factor: 2.300

6.  Successful thrombolytic treatment of prosthetic mitral valve thrombosis.

Authors:  Emine Gazi; Burak Altun; Ahmet Temiz; Yucel Colkesen
Journal:  BMJ Case Rep       Date:  2013-06-07

7.  Oral Anticoagulant Therapy for Early Post-TAVI Thrombosis.

Authors:  Neil Ruparelia
Journal:  Interv Cardiol       Date:  2018-01

8.  St. Jude prosthetic valve obstruction in the mitral position.

Authors:  Katsuhiko Matsuyama; Tomohiro Nakayama; Hiroaki Hagiwara
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-05-06

Review 9.  Antithrombotic therapies in patients with prosthetic heart valves: guidelines translated for the clinician.

Authors:  Tiago L L Leiria; Renato D Lopes; Judson B Williams; Jason N Katz; Renato A K Kalil; John H Alexander
Journal:  J Thromb Thrombolysis       Date:  2011-05       Impact factor: 2.300

10.  Prosthetic heart valve obstruction: thrombolysis or surgical treatment?

Authors:  Maria Bonou; Konstantinos Lampropoulos; John Barbetseas
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2012-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.